In Turkey, information on human immunodeficiency virus (HIV) infection is provided by the Public Health Agency of the Ministry of Health and the Directorate-General for Health Services of the Ministry of Health and is complemented by the results of hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV testing among people who inject drugs (PWID) who have been admitted to specialised treatment centres.
|Data from 2015 (HIV) and from 2017 (HCV).|
The available data indicate that there were 14 newly diagnosed cases of HIV infection linked to injecting drug use in 2017, corresponding to 1 % of new cases with information on the route of transmission. None of the almost 3 000 drug treatment clients who were tested in 2015 was HIV positive, while 4 out of 10 treatment clients tested positive for HCV antibodies.
The prevalence of HBV infection among PWID who are in treatment is within the range of HBV prevalence among the general population: around 3 % of females and 4 % of males are HBV positive.